Skip to main content
Erschienen in: International Urology and Nephrology 12/2014

01.12.2014 | Nephrology - Original Paper

Difference between true functional haemoglobin and pre-dialysis haemoglobin is associated with plasma volume variation: a multicentre study

verfasst von: Esteban Siga, Miguel Fernandez, Mario Galarza, Vito Mesina, Hugo De Palma, Raul Coste

Erschienen in: International Urology and Nephrology | Ausgabe 12/2014

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Due to the well-known intradialytic haemoglobin (Hb) change, it has been suggested that true functional Hb differs from pre-dialysis Hb. However, mechanisms of this change are not understood properly. We aimed at studying the role of plasma volume variation.

Methods

This is a multicentre study with two consecutive phases. First, true functional Hb was predicted by Krisper’s formula that estimates time-averaged haemoglobin concentration (TAC-Hb) and by the average (Avg-Hb) of Pre-Hb and Post-Hb (n = 346). Erythropoiesis-stimulating agent (ESA) doses were estimated according to the FDA instructions. Second, we investigated the correlations between Hb changes (ΔHb), body weight loss (ΔBW) and relative plasma volume changes (%ΔPV) in subjects with a weight gain higher than 1 kg (n = 208).

Results

First: Avg-Hb and TAC-Hb were similar to each other and higher than midweek Pre-Hb (p < 0. 002). Odds of having an Hb change >1 g/dL were 0.415. Odds were similar in both women and men [odds ratio (OR) 0.923; 95 % confidence interval (CI) 0.591–1.441]. If ESA doses were estimated by TAC-Hb or Avg-Hb instead of Pre-Hb, they should be lower in 40 % of the 346 patients. Second: Mean %ΔPV was −12.1 % (95 % CI −10.72/−13.48), and mean ΔHb was 1.1 g/dL (95 % CI 0.97/1.25). Correlation between ΔHb and %ΔPV was −0.92 (r 2 0.84) whereas that of ΔHb/ΔBW was just −0.45 (r 2 0.21; p < 0.000). Prevalence of ΔHb >1 g/dL was independent of ΔBW from 1.4 to 6.3 kg. By contrast, prevalence of ΔHb >1 g/dL in %ΔPV quartiles was clearly linear: 0, 52, 90 and 100 %, respectively.

Conclusions

Plasma volume variations play a major role in intradialytic Hb change. True functional Hb should be estimated in all patients with a weight gain higher than 1 kg.
Literatur
1.
Zurück zum Zitat Pfeffer MA, Burdmann EA, Chen CY, Cooper ME, de Zeeuw D, Eckardt KU et al (2009) A trial of darbepoetin alfa in type 2 diabetesand chronic kidney disease. N Engl J Med 361:2019–2032PubMedCrossRef Pfeffer MA, Burdmann EA, Chen CY, Cooper ME, de Zeeuw D, Eckardt KU et al (2009) A trial of darbepoetin alfa in type 2 diabetesand chronic kidney disease. N Engl J Med 361:2019–2032PubMedCrossRef
2.
Zurück zum Zitat Besarab A, Bolton WK, Browne JK, Egrie JC, Nissenson AR, Okamoto DM et al (1998) The effects of normal as compared with low hematocrit values inpatients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med 339:584–590PubMedCrossRef Besarab A, Bolton WK, Browne JK, Egrie JC, Nissenson AR, Okamoto DM et al (1998) The effects of normal as compared with low hematocrit values inpatients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med 339:584–590PubMedCrossRef
3.
Zurück zum Zitat Singh AK, Szczech L, Tang KL, Barnhart H, Sapp S, Wolfson M et al (2006) Correction of anaemia with epoetin alpha in chronic kidney disease. N Engl J Med 355:2085–2098PubMedCrossRef Singh AK, Szczech L, Tang KL, Barnhart H, Sapp S, Wolfson M et al (2006) Correction of anaemia with epoetin alpha in chronic kidney disease. N Engl J Med 355:2085–2098PubMedCrossRef
4.
Zurück zum Zitat Drueke TB, Locatelli F, Clyne N, Eckardt KU, Macdougall IC, Tsakiris D et al (2006) Normalization of hemoglobin level in patients with chronic kidney disease and anaemia. N Engl J Med 355:2071–2084PubMedCrossRef Drueke TB, Locatelli F, Clyne N, Eckardt KU, Macdougall IC, Tsakiris D et al (2006) Normalization of hemoglobin level in patients with chronic kidney disease and anaemia. N Engl J Med 355:2071–2084PubMedCrossRef
5.
Zurück zum Zitat Unger EF, Thompson AM, Blank MJ, Temple R (2010) Erythropoiesis-stimulating agents, time for a reevaluation. N Engl J Med 362(3):189–192PubMedCrossRef Unger EF, Thompson AM, Blank MJ, Temple R (2010) Erythropoiesis-stimulating agents, time for a reevaluation. N Engl J Med 362(3):189–192PubMedCrossRef
6.
Zurück zum Zitat Vlassopoulos D, Sonikian M, Dardioti V, Hadjiconstaninou V (1999) Target haematocrit during erythropoietin treatment in dialysis patients. Which value is ‘true-functional haematocrit’? Nephrol Dial Transplant 14:1340PubMedCrossRef Vlassopoulos D, Sonikian M, Dardioti V, Hadjiconstaninou V (1999) Target haematocrit during erythropoietin treatment in dialysis patients. Which value is ‘true-functional haematocrit’? Nephrol Dial Transplant 14:1340PubMedCrossRef
7.
Zurück zum Zitat Krisper P, Quehenberger F, Schneditz D, Holzer H, Polaschegg HD (2003) Prediction of time-averaged concentration of haemoglobin in haemodialysis patients. Nephrol Dial Transpl 18:2082–2087CrossRef Krisper P, Quehenberger F, Schneditz D, Holzer H, Polaschegg HD (2003) Prediction of time-averaged concentration of haemoglobin in haemodialysis patients. Nephrol Dial Transpl 18:2082–2087CrossRef
8.
Zurück zum Zitat Castillo et al (2012) Should we adjust erythropoiesis stimulating agent dosage to postdialysis hemoglobin levels? A pilot study. BMC Nephrol 13:60CrossRef Castillo et al (2012) Should we adjust erythropoiesis stimulating agent dosage to postdialysis hemoglobin levels? A pilot study. BMC Nephrol 13:60CrossRef
9.
Zurück zum Zitat Korzets A, Ori Y, Zevin D, Gafter U (2002) Posthemodialysis hemoglobin levels: overdue or not? Am J Kidney Dis 40(4):873PubMedCrossRef Korzets A, Ori Y, Zevin D, Gafter U (2002) Posthemodialysis hemoglobin levels: overdue or not? Am J Kidney Dis 40(4):873PubMedCrossRef
10.
Zurück zum Zitat Bellizzi V, Minutolo R, Terracciano V et al (2002) Influence of the cyclic variation of hydration status on hemoglobin levels in hemodialysis patients. Am J Kidney Dis 40:549–555PubMedCrossRef Bellizzi V, Minutolo R, Terracciano V et al (2002) Influence of the cyclic variation of hydration status on hemoglobin levels in hemodialysis patients. Am J Kidney Dis 40:549–555PubMedCrossRef
11.
Zurück zum Zitat Geller A, DeVita M, Marku-Podvorica J, Rosenstock J, Panagopoulos G, Michelis M. Increase in post-dialysis hemoglobin can be out of proportion and unrelated to ultrafiltration. Dialysis & Transplantation 2010 (February: 1–4) Geller A, DeVita M, Marku-Podvorica J, Rosenstock J, Panagopoulos G, Michelis M. Increase in post-dialysis hemoglobin can be out of proportion and unrelated to ultrafiltration. Dialysis & Transplantation 2010 (February: 1–4)
12.
Zurück zum Zitat Minutolo R, De Nicola L, Bellizzi V (2003) Intra- and post-dialytic changes of haemoglobin concentrations in non-anaemic haemodialysis patients. Nephrol Dial Transpl 18:2606–2612CrossRef Minutolo R, De Nicola L, Bellizzi V (2003) Intra- and post-dialytic changes of haemoglobin concentrations in non-anaemic haemodialysis patients. Nephrol Dial Transpl 18:2606–2612CrossRef
13.
Zurück zum Zitat Daugirdas JT, Tattersall J (2010) Effect of treatment spacing and frequency on three measures of equivalent clearance, including standard Kt/V. Nephrol Dial Transpl 25(2):558–561CrossRef Daugirdas JT, Tattersall J (2010) Effect of treatment spacing and frequency on three measures of equivalent clearance, including standard Kt/V. Nephrol Dial Transpl 25(2):558–561CrossRef
15.
Zurück zum Zitat van Beaumont W (1972) Evaluation of hemoconcentration from hematocrit measurements. J Appl Physiol. 32(5):712–713PubMed van Beaumont W (1972) Evaluation of hemoconcentration from hematocrit measurements. J Appl Physiol. 32(5):712–713PubMed
16.
Zurück zum Zitat Koomans H, Geers A (1984) Dorhout Mees E. Plasma volume recovery after ultrafiltration in patients with chronic renal failure. Kidney Int 26:848–854PubMedCrossRef Koomans H, Geers A (1984) Dorhout Mees E. Plasma volume recovery after ultrafiltration in patients with chronic renal failure. Kidney Int 26:848–854PubMedCrossRef
17.
Zurück zum Zitat Bland J, Altman G (2003) Applying the right statistics: analyses of measurement studies. Ultrasound Obstet Gynecol 22:85–93PubMedCrossRef Bland J, Altman G (2003) Applying the right statistics: analyses of measurement studies. Ultrasound Obstet Gynecol 22:85–93PubMedCrossRef
19.
Zurück zum Zitat Movilli E, Cancarini GC, Cassamali S, Camerini C, Brunori G, Maffei C, Maiorca R (2004) Inter-dialytic variations in blood volume and total body water in uraemic patients treated by dialysis. Nephrol Dial Transplant 19:185–189PubMedCrossRef Movilli E, Cancarini GC, Cassamali S, Camerini C, Brunori G, Maffei C, Maiorca R (2004) Inter-dialytic variations in blood volume and total body water in uraemic patients treated by dialysis. Nephrol Dial Transplant 19:185–189PubMedCrossRef
20.
Zurück zum Zitat Movilli E, Pertica N, Camerini C et al (2002) Predialysis versus postdialysis hematocrit evaluation during erythropoietin therapy. Am J Kidney Dis 39:850–853PubMedCrossRef Movilli E, Pertica N, Camerini C et al (2002) Predialysis versus postdialysis hematocrit evaluation during erythropoietin therapy. Am J Kidney Dis 39:850–853PubMedCrossRef
21.
Zurück zum Zitat Siga E, Aiziczon D, Diaz G (2011) Optimizacion del tratamiento con hierro endovenoso en hemodiálisis. Estudio Clinico prospectivo a largo plazo. Medicina (Bs. As) 71:9–14 Siga E, Aiziczon D, Diaz G (2011) Optimizacion del tratamiento con hierro endovenoso en hemodiálisis. Estudio Clinico prospectivo a largo plazo. Medicina (Bs. As) 71:9–14
Metadaten
Titel
Difference between true functional haemoglobin and pre-dialysis haemoglobin is associated with plasma volume variation: a multicentre study
verfasst von
Esteban Siga
Miguel Fernandez
Mario Galarza
Vito Mesina
Hugo De Palma
Raul Coste
Publikationsdatum
01.12.2014
Verlag
Springer Netherlands
Erschienen in
International Urology and Nephrology / Ausgabe 12/2014
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-014-0774-2

Weitere Artikel der Ausgabe 12/2014

International Urology and Nephrology 12/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.